Registered Nurse Robert Orallo administers the Pfizer Covid-19 vaccine at the Blood Bank of Alaska in Anchorage on March 19, 2021. FREDERIC J. BROWN/AFP via Getty Images
The FDA was burning the midnight oil last night when it paved the way for some people with weakened immune systems to get a third dose of a vaccine.
Doctors can now consider giving third doses of the shots made by Pfizer/BioNTech and Moderna to people who are immunocompromised.
The decision doesn't yet open the door for a broader booster shot campaign in the US. Israel, on the other hand, is forging ahead. The country is giving extra doses to everyone over 50, as well as to immunocompromised individuals, healthcare workers, and prisoners.
Werner Baumann, right, CEO of Bayer AG, and Werner Wenning, chairman of the Supervisory Board of Bayer AG, stand on stage at the Bayer Annual Stockholders' Meeting and shake hands. Bayer announced this week that it would acquire Vividion Therapeutics. Guido Kirchner/picture alliance via Getty Images
Last week, I told y'all about Allison DeAngelis and Andrew Dunn's conversations with biotech VCs, and the startups they bet will take off in the next 12 months.
When Dollar General in July said that it had hired its first-ever chief medical officer, our ears perked up.
We've been tracking different retailers' ambitions in healthcare, but this was the first we were really hearing from some of the dollar stores.
It's an intriguing idea given Dollar General's reach in rural areas of the US where access to healthcare - including pharmacies - can be difficult to come by.
Megan Hernbroth and Shelby Livingston asked industry experts and analysts about what we can expect from Dollar General.
